ArticleBMC microbiology2026
Isolation and characterization of phage vB_KpnS_SXK7 against multidrug-resistant Klebsiella pneumoniae and the mechanism of O-antigen-associated phage resistance.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The increasing prevalence of multidrug-resistant (MDR) Klebsiella pneumoniae necessitates alternative therapeutic strategies. Here, we isolated and characterized a lytic phage, vB_KpnS_SXK7, from hospital sewage and investigated the host's resistance mechanism. Morphological analysis identified it as a siphovirus-type phage. It exhibited a 30-min latent period, a burst size of 270 PFU/infected cell, and stability across pH 5-12 and temperatures up to 60 °C. Host range testing against 25 K. pneumoniae strains showed that vB_KpnS_SXK7 lysed 9 strains (36%). Whole-genome sequencing revealed a 49.1-kb circular dsDNA genome lacking tRNA, virulence, or antibiotic-resistance genes, confirming its safety profile. In vitro, vB_KpnS_SXK7 reduced bacterial viability within 2 h. In a Galleria mellonella infection model, a single dose (MOI 100) rescued 80% of larvae from lethal challenge without toxicity. Genomic analysis of resistant mutant SXK7-R11 identified a single-nucleotide deletion in wzm, which encodes an ABC transporter permease essential for O-antigen assembly. This mutation impaired phage adsorption, which was restored by genetic complementation. These findings establish vB_KpnS_SXK7 as a promising preclinical candidate but highlight its vulnerability to resistance mechanisms involving O‑antigen‑associated pathways, supporting the development of phage cocktails targeting multiple receptors against MDR infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.